Published in Br J Cancer on November 01, 1981
The initial immune reaction to a new tumor antigen is always stimulatory and probably necessary for the tumor's growth. Clin Dev Immunol (2010) 0.93
Dynamics of the cell-mediated immune response to tumour growth. Philos Trans A Math Phys Eng Sci (2017) 0.79
Immunologgical self-tolerance in allophenic and embryo-aggregated mice. Theor Biol Med Model (2010) 0.77
Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning. Oncotarget (2016) 0.76
In vivo detection and partial characterization of effector and suppressor cell populations in spleens of mice with large metastatic fibrosarcomas. Br J Cancer (1985) 0.76
A Dynamic Model of Immune Responses to Antigen Presentation Predicts Different Regions of Tumor or Pathogen Elimination. Cell Syst (2017) 0.75
A Century of Radiation Therapy and Adaptive Immunity. Front Immunol (2017) 0.75
A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44
Regulation of cellular and humoral immune responses by T-cell subclasses. Cold Spring Harb Symp Quant Biol (1977) 5.21
Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes. J Exp Med (1977) 3.38
Cell-to-cell interaction in the immune response. VI. Contribution of thymus-derived cells and antibody-forming cell precursors to immunological memory. J Exp Med (1971) 3.14
Suppressor cells: permitters and promoters of malignancy? Adv Cancer Res (1979) 1.33
Recent trends in tumor immunology. Isr J Med Sci (1966) 1.00
Correlation of "sneaking through" of tumor cells with specific immunological impairment of the host. Eur J Immunol (1975) 0.99
The concept of immunological surveillance against neoplasia. Transplant Rev (1976) 0.96
T cell subset interactions in the regulation of syngeneic tumor immunity. Fed Proc (1981) 0.94
Low numbers of tumor cells suppress the host immune system. Adv Exp Med Biol (1976) 0.83
The role of antibody in the inhibition of the growth of Meth.A tumour in syngeneic experiments in vivo and in vitro. Clin Exp Immunol (1978) 0.82
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med (1972) 4.63
Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55
Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med (1970) 4.34
Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04
Induction of self-tolerance in mature peripheral B lymphocytes. Nature (1989) 4.02
Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis. J Exp Med (1970) 3.40
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06
Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77
Cell interactions in the immune response in vitro. IV. Comparison of the effects of antigen-specific and allogeneic thymus-derived cell factors. J Exp Med (1972) 2.48
Mycobacterium leprae antigens involved in human immune responses. I. Identification of four antigens by monoclonal antibodies. J Immunol (1985) 2.40
Dissection of immunoregulatory subpopulations of T lymphocytes within the helper and suppressor sublineages in man. J Immunol (1982) 2.29
Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15
Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science (1991) 1.97
The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96
Cell interactions in the immune response in vitro. 3. Specific collaboration across a cell impermeable membrane. J Exp Med (1972) 1.96
Circulating T and B lymphocytes of the mouse. II. Lifespan. Cell Immunol (1973) 1.94
Receptor for antibody-antigen complexes used to separate T cells from B cells. Nat New Biol (1972) 1.87
Immunoreactivity of a 70 kD protein purified from Mycobacterium bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography. J Exp Med (1986) 1.78
Homology of the 70-kilodalton antigens from Mycobacterium leprae and Mycobacterium bovis with the Mycobacterium tuberculosis 71-kilodalton antigen and with the conserved heat shock protein 70 of eucaryotes. Infect Immun (1989) 1.75
Mechanisms for eosinophilic and neutrophilic leucocytoses. Br Med J (1971) 1.66
Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants. J Exp Med (1975) 1.58
Specific collaboration between T and B lymphocytes across a cell impermeable membrane in vitro. Nat New Biol (1972) 1.49
Mechanism of eosinophilia. 3. Suppression of eosinophilia by agents known to modify immune responses. Blood (1970) 1.48
Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46
Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival. Blood (2001) 1.45
Silicone breast implants--where have we been and where are we now? Aust N Z J Med (1996) 1.39
Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood (2001) 1.37
A subpopulation of T cells bearing Fc receptors. J Immunol (1975) 1.35
Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med (1992) 1.33
Sequence and immunogenicity of the 70-kDa heat shock protein of Mycobacterium leprae. J Immunol (1991) 1.31
Humoral and cell mediated responses in vitro of spleen cells from mice with thymic aplasia (nude mice). Aust J Exp Biol Med Sci (1972) 1.26
Autoantibodies to type II collagen: occurrence in rheumatoid arthritis, other arthritides, autoimmune connective tissue diseases, and chronic inflammatory syndromes. Ann Rheum Dis (1988) 1.26
The characterization and immunoreactivity of a 70 kD protein common to Mycobacterium leprae and Mycobacterium bovis (BCG). Lepr Rev (1986) 1.24
Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields. Radiat Res (1997) 1.23
Immune function in aged mice. II. B-cell function. Cell Immunol (1977) 1.20
HLA family studies and multiple sclerosis: A common gene, dominantly expressed. Hum Immunol (1981) 1.19
Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells. Int J Cancer (1975) 1.18
Induction of immunoglobulin secreting cells in the human autologous mixed leukocyte reaction: regulation by helper and suppressor lymphocyte subsets defined with monoclonal antibodies. J Immunol (1981) 1.17
Intrinsic B-cell hyporesponsiveness accounts for self-tolerance in lysozyme/anti-lysozyme double-transgenic mice. Proc Natl Acad Sci U S A (1990) 1.17
Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids. Infect Immun (1989) 1.16
Reduced CD4+ T cells and candidiasis in absence of HIV infection. Lancet (1989) 1.16
B cell life span: a review. Immunol Cell Biol (1997) 1.15
Is C-reactive protein really useful in preterm premature rupture of the membranes? Br J Obstet Gynaecol (1987) 1.15
Suppressor cells in humoral immunity and tolerance. Br Med Bull (1976) 1.14
Influences on the lifespan of B cell subpopulations defined by different phenotypes. Eur J Immunol (1997) 1.14
Suppressor T cell memory. II. The role of memory suppressor T cells in tolerance to human gamma globulin. J Exp Med (1983) 1.14
Cell interactions in the immune response in vitro. I. Metabolic activities of T cells in a collaborative antibody response. Eur J Immunol (1972) 1.13
Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy. J Exp Med (1997) 1.13
The need for central and peripheral tolerance in the B cell repertoire. Science (1990) 1.12
B cell activation, tolerance and antigen-presenting function. Curr Opin Immunol (1995) 1.12
Blocking of human T lymphocyte functions by anti-Leu-2 and anti-Leu-3 antibodies: differential inhibition of proliferation and suppression. J Immunol (1983) 1.11
Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci U S A (1994) 1.11
Immune function in aged mice. I. T-cell responsiveness using phytohaemagglutinin as a functional probe. Cell Immunol (1977) 1.10
Suppressor T-cell memory. Nature (1978) 1.10
Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme. Proc Natl Acad Sci U S A (1991) 1.09
Immune complexes in thrombocytopenic patients: cause or effect? Br J Haematol (1980) 1.09
Immune function in aged mice. IV. Loss of T cell and B cell function in thymus-dependent antibody responses. Eur J Immunol (1978) 1.09
Post-mammoplasty connective tissue disease. Arthritis Rheum (1982) 1.08
Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol (1986) 1.08
Antigens of Mycobacterium leprae identified by immunoprecipitation with sera from leprosy and tuberculosis patients. Clin Exp Immunol (1988) 1.05
Dominant cell wall proteins of Mycobacterium leprae recognized by monoclonal antibodies. Clin Exp Immunol (1987) 1.04
Mechanisms of tolerance to self. Curr Opin Immunol (1996) 1.04
Loss of immune competence with age may be due to a qualitative abnormality in lymphocyte membranes. Nature (1979) 1.03
Individuals from different populations identify multiple and diverse T-cell determinants on mycobacterial HSP70. Scand J Immunol (1994) 1.03
Suppressor T cells in tolerance to non-self and self antigens. Cold Spring Harb Symp Quant Biol (1977) 1.03
Autoantibodies to retinal astrocytes associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (1990) 1.02
T cell reactivity to the purified mycobacterial antigens p65 and p70 in leprosy patients and their household contacts. Clin Exp Immunol (1990) 1.01
Variable gene usage of T cell receptor gamma- and delta-chain transcripts expressed in synovia and peripheral blood of patients with rheumatoid arthritis. Clin Exp Immunol (1992) 1.00
Immunoglobulin secretion in the human autologous mixed leukocyte reaction. Definition of a suppressor-amplifier circuit using monoclonal antibodies. J Exp Med (1982) 0.98
Selective cytotoxicity of anti-kappa serum for B lymphocytes. Nat New Biol (1972) 0.98
HLA-DW2, viral immunity and family studies in multiple sclerosis. J Neurol Sci (1977) 0.97
Complementary relationship between repetitive sequences in the SV40 early gene pre-promoter enhancing region and big-T antigen splice junction exons. J Theor Biol (1984) 0.96
Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice. J Exp Med (1998) 0.95
Thymoma and late onset mucocutaneous candidiasis associated with a plasma inhibitor of cell-mediated immune function. J Clin Lab Immunol (1980) 0.95
Deficiency of C4A is a genetic determinant of systemic lupus erythematosus in three ethnic groups. J Immunogenet (1988) 0.95
Anti-neutrophil cytoplasmic antibodies (ANCA): their detection and significance: report from workshops. Pathology (1994) 0.94
What are killer cells and what do they do? Blood Rev (1988) 0.94
T cell-dependent suppression of antibody production. I. Characteristics of suppressor T cells following tolerance induction. Eur J Immunol (1978) 0.92
The variable C-terminal region of the Mycobacterium leprae 70-kilodalton heat shock protein is the target for humoral immune responses. Infect Immun (1992) 0.92
DNA-DR typing shows HLA-DRw11 RFLPs are increased in frequency in both progressive systemic sclerosis and CREST variants of scleroderma. Tissue Antigens (1989) 0.92
Total lipodystrophy--a report of a case with peripheral neuropathy and glomerulonephritis. Aust N Z J Med (1983) 0.92
Antigens and allergens from the common house dust mite Dermatophagoides pteronyssinus. Part II. Identification of the major IgE-binding antigens by crossed radioimmunoelectrophoresis. J Allergy Clin Immunol (1984) 0.91
Human antigen-specific IgA responses in blood and secondary lymphoid tissue: an analysis of help and suppression. J Immunol (1984) 0.91
A role for suppressor T cells in induction of self-tolerance. Proc Natl Acad Sci U S A (1985) 0.91
Induction of memory and effector suppressor T cells by perinatal exposure to antigen. Eur J Immunol (1984) 0.91
Immune function in aged mice. V. Role of suppressor cells. J Immunol (1980) 0.90
T cell clones from a non-leprosy exposed subject recognize the Mycobacterium leprae 18-kD protein. Clin Exp Immunol (1995) 0.89
Alpha-interferon (Wellferon) as an adjunct to standard surgical therapy in the management of recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol (1988) 0.88
Use of phenolic glycolipid 1 for serodiagnosis of leprosy in a high prevalence village in Papua New Guinea. Trans R Soc Trop Med Hyg (1987) 0.88
Detection of membrane-associated antigens on lymphoid cells by antibody coupled to staphylococcal protein A. J Immunol (1975) 0.88
Subclinical infection with Mycobacterium leprae--a problem for leprosy control strategies. Trans R Soc Trop Med Hyg (1993) 0.87
Immune system of the gastrointestinal tract. Int Rev Physiol (1983) 0.87
Identification of biological false positives in anti-HIV antibody tests. AIDS (1987) 0.86
Gm typing by immunoglobulin heavy-chain gene RFLP analysis. Am J Hum Genet (1988) 0.86
Transfer factor in treatment of multiple sclerosis. Lancet (1980) 0.86